Yasuyoshi Miyata Selected Research

Yasuyoshi Miyata Research Topics

Disease

78	Neoplasms (Cancer) 02/2023 - 09/2002
30	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 03/2003
27	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2003
23	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021 - 02/2006
18	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
8	Overactive Urinary Bladder (Overactive Bladder) 07/2022 - 07/2016
6	Lower Urinary Tract Symptoms 03/2022 - 07/2016
6	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2015
6	Carcinogenesis 10/2021 - 01/2017
4	Disease Progression 01/2022 - 08/2014
4	Urologic Neoplasms (Urological Cancer) 01/2018 - 02/2013
4	Carcinoma (Carcinomatosis) 08/2012 - 06/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2022 - 07/2019
3	Spinal Cord Diseases 07/2021 - 01/2018
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 07/2021 - 01/2018
3	Fatigue 10/2020 - 10/2015
3	Nocturia 04/2019 - 01/2017
3	Pain (Aches) 10/2015 - 11/2005
3	Transitional Cell Carcinoma 06/2006 - 03/2004
2	Hypertension (High Blood Pressure) 03/2022 - 12/2015
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 01/2021
2	Erectile Dysfunction 01/2022 - 07/2004
2	Renal Insufficiency (Renal Failure) 12/2021 - 01/2013
2	Atherosclerosis 12/2021 - 08/2005
2	Hypoxia (Hypoxemia) 08/2021 - 03/2007
2	Anorexia 10/2020 - 12/2018
2	Autoimmune Diseases (Autoimmune Disease) 10/2018 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 06/2013
2	Peritonitis 01/2014 - 09/2006
2	Fibrosis (Cirrhosis) 01/2013 - 12/2005

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2002
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 03/2003
10	Matrix Metalloproteinases (MMPs)IBA 05/2019 - 05/2003
7	royal jellyIBA 12/2021 - 10/2018
7	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 06/2011
7	Gemcitabine FDA Link 07/2020 - 06/2011
6	Dinoprostone (PGE2)FDA Link 10/2021 - 01/2005
6	AntigensIBA 10/2018 - 01/2016
6	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017 - 05/2003
5	mirabegronIBA 07/2022 - 07/2016
5	Biomarkers (Surrogate Marker)IBA 08/2021 - 11/2007
5	PolyphenolsIBA 01/2021 - 06/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 12/2011
5	TeaIBA 01/2019 - 06/2010
4	ProstaglandinsIBA 10/2021 - 01/2013
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2020 - 05/2003
4	Vascular Endothelial Growth FactorsIBA 01/2017 - 02/2006
4	Formaldehyde (Formol)FDA Link 12/2014 - 01/2005
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2011 - 03/2003
4	Proto-Oncogene Proteins c-metIBA 04/2009 - 03/2003
3	Sunitinib (Sutent)FDA Link 01/2022 - 06/2018
3	Macrophage Colony-Stimulating FactorIBA 12/2021 - 08/2005
3	stage-specific embryonic antigen-4IBA 07/2021 - 10/2019
3	ThrombospondinsIBA 05/2021 - 05/2003
3	SaltsIBA 01/2021 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 11/2020 - 12/2018
3	Heme Oxygenase-1IBA 07/2020 - 12/2014
3	4N1K peptideIBA 05/2019 - 05/2003
3	AntibodiesIBA 01/2017 - 08/2006
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2009 - 05/2003
3	Phosphotransferases (Kinase)IBA 01/2009 - 03/2003
2	CalciumIBA 03/2022 - 08/2005
2	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2020
2	Malondialdehyde (Propanedial)IBA 12/2021 - 08/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2021 - 10/2018
2	8-Hydroxy-2'-DeoxyguanosineIBA 12/2021 - 08/2021
2	Hormones (Hormone)IBA 09/2021 - 01/2016
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2021 - 01/2017
2	Ceruloplasmin (Ferroxidase)IBA 08/2021 - 07/2021
2	Androgen Receptors (Androgen Receptor)IBA 07/2021 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 10/2017
2	AntioxidantsIBA 05/2019 - 10/2018
2	Thrombospondin 1IBA 05/2019 - 06/2013
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 06/2013
2	CreatinineIBA 01/2018 - 01/2014
2	AndrogensIBA 04/2017 - 01/2017
2	Vascular Endothelial Growth Factor CIBA 01/2017 - 02/2006
2	Guanosine Triphosphate (GTP)IBA 01/2017 - 06/2010
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2015 - 08/2005
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2014 - 01/2009
2	Vascular Endothelial Growth Factor DIBA 12/2014 - 02/2006
2	NitrosaminesIBA 01/2013 - 06/2010
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2011 - 02/2009
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2009 - 12/2006
2	Tyrosine (L-Tyrosine)FDA Link 04/2009 - 08/2006
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2008 - 07/2006
2	Mitogen-Activated Protein KinasesIBA 02/2008 - 07/2006

Therapy/Procedure

36	Therapeutics 01/2022 - 02/2003
9	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 06/2004
5	Nephrectomy 12/2022 - 01/2009
5	Castration 09/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 04/2020 - 04/2006
4	Molecular Targeted Therapy 12/2020 - 08/2014
4	Aftercare (After-Treatment) 01/2018 - 09/2012
3	Renal Dialysis (Hemodialysis) 12/2021 - 07/2004
3	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 07/2019
2	Kidney Transplantation 02/2023 - 07/2019
2	Radiotherapy 08/2014 - 04/2006
2	Combination Drug Therapy (Combination Chemotherapy) 12/2011 - 06/2011